Stress damage to nonischemic divisions of the heart in experimental infarction and its prevention

Clinical Cardiology
|April 1, 1983
PubMed

Insights

Emotional-painful stress, not just ischemia, impairs nonischemic heart function after myocardial infarction. Propranolol and membrane stabilizers can prevent these stress-induced contractile deficits in heart muscle.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Stress Physiology

Background:

  • Myocardial infarction (MI) creates ischemic zones, but nonischemic areas also show functional deficits.
  • These deficits in nonischemic regions are hypothesized to stem from infarction-associated emotional-painful stress.

Purpose of the Study:

  • To investigate the role of emotional-painful stress in the contractile dysfunction of nonischemic heart regions following myocardial infarction.
  • To assess the effects of stress and potential therapeutic interventions on myocardial contractility.

Main Methods:

  • Studied contractile function of the isolated right auricle (a nonischemic cardiac region) in rats post-left ventricle myocardial infarction.
  • Induced stress in control rats to replicate infarction-induced stress effects.
  • Administered propranolol, antioxidant ionol, nicotinamide, and chloroquine to evaluate their preventative effects.

Main Results:

  • Myocardial infarction led to reduced atrial extensibility, depressed Starling curve, decreased maximal systolic tension, and lower resistance to hypoxia and calcium excess.
  • These contractile disturbances were fully replicated by emotional-painful stress alone and largely prevented by propranolol.
  • Membrane-stabilizing agents (ionol, nicotinamide, chloroquine) mitigated stress-induced contractile dysfunction in the context of infarction.

Conclusions:

  • Emotional-painful stress significantly contributes to the contractile dysfunction observed in nonischemic heart regions after myocardial infarction.
  • Propranolol and agents stabilizing cardiomyocyte membranes show potential for preventing or limiting these stress-mediated cardiac deficits.
  • Further research is warranted to explore therapeutic applications of these findings in ischemic heart disease.